Exparel 133 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FQPJD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,218
Award facts
- Contract value 100% obligated
- $1,218.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,218.44 by the Defense Logistics Agency (DLA) on September 4, 2025. The contract calls for the delivery of EXPAREL 133 mg/10 mL vials, a liposomal bupivacaine product used for local anesthetic infiltration during surgical procedures. The delivery order is set to be completed by September 25, 2025, with performance occurring at the contractor's Park Ridge, Illinois location. This award includes no set-aside designation.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. The DLA's pharmaceutical supply portfolio through this vehicle supports military health system needs, and DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized medications and medical consumables to military healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FQPJD?
SPE2DB25FQPJD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FQPJD worth?
The government has obligated $1,218 on SPE2DB25FQPJD.
Is contract SPE2DB25FQPJD an order under another contract?
Yes. SPE2DB25FQPJD is a delivery order under SPE2DB25D9240, an indefinite delivery contract.
Was contract SPE2DB25FQPJD competed?
The extent of competition for SPE2DB25FQPJD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award